97 related articles for article (PubMed ID: 8687346)
21. Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity.
Coote JH; Wylie JP; Cowan RA; Logue JP; Swindell R; Livsey JE
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1121-7. PubMed ID: 19131179
[TBL] [Abstract][Full Text] [Related]
22. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer.
Beard CJ; Lamb C; Buswell L; Schneider L; Propert KJ; Gladstone D; D'Amico A; Kaplan I
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):257-62. PubMed ID: 9607338
[TBL] [Abstract][Full Text] [Related]
23. Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?
Vistad I; Cvancarova M; Fosså SD; Kristensen GB
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1335-42. PubMed ID: 18355976
[TBL] [Abstract][Full Text] [Related]
24. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.
Hamstra DA; Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Daignault-Newton S; Fischer-Valuck BW; Chundury A; Gay H; Bosch W; Michalski J
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):976-985. PubMed ID: 28209443
[TBL] [Abstract][Full Text] [Related]
25. [Quality of life after radiotherapy for prostate cancer].
Joly F; Degrendel AC; Guizard AV
Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
[TBL] [Abstract][Full Text] [Related]
26. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
[TBL] [Abstract][Full Text] [Related]
27. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
Pinkawa M; Piroth MD; Holy R; Fischedick K; Klotz J; Székely-Orbán D; Eble MJ
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):23-8. PubMed ID: 20832182
[TBL] [Abstract][Full Text] [Related]
28. Does pelvic lymph nodes irradiation using intensity modulated radiation therapy increase rectal and bladder toxicities in patients with prostate carcinoma?
Garipagaoglu M; Sengoz M; Senkesen O; Ozan Göksel E; Tezcanli E; Kucucuk H; Aslay I
J BUON; 2010; 15(4):668-73. PubMed ID: 21229627
[TBL] [Abstract][Full Text] [Related]
29. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.
Harsolia A; Vargas C; Yan D; Brabbins D; Lockman D; Liang J; Gustafson G; Vicini F; Martinez A; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1100-9. PubMed ID: 17967304
[TBL] [Abstract][Full Text] [Related]
30. [Cancer of the prostate: intolerability and morbidity of external radiotherapy].
Douchez J; Allain YM; Cellier P; Fenton J; Fregevu Y; Hay M; Le Bourgeois JP; Vincent F
Bull Cancer; 1985; 72(6):573-7. PubMed ID: 4092107
[TBL] [Abstract][Full Text] [Related]
31. [Three-dimensional conformal radiation therapy for prostate cancer in Hamamatsu Medical Center].
Kanda T; Nakagomi K; Goto S; Iijima M
Hinyokika Kiyo; 2007 Jan; 53(1):9-12. PubMed ID: 17310762
[TBL] [Abstract][Full Text] [Related]
32. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
33. Radiation-induced impairment of urinary bladder function. Assessment of micturition volumes.
Hanfmann B; Engels M; Dörr W
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():96-8. PubMed ID: 9830469
[TBL] [Abstract][Full Text] [Related]
34. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
35. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer.
Teh BS; Mai WY; Augspurger ME; Uhl BM; McGary J; Dong L; Grant WH; Lu HH; Woo SY; Carpenter LS; Chiu JK; Butler EB
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):465-72. PubMed ID: 11173142
[TBL] [Abstract][Full Text] [Related]
36. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer.
Henriksson R; Franzén L; Littbrand B
J Clin Oncol; 1992 Jun; 10(6):969-75. PubMed ID: 1588377
[TBL] [Abstract][Full Text] [Related]
37. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
[TBL] [Abstract][Full Text] [Related]
38. Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer.
Carillo V; Cozzarini C; Rancati T; Avuzzi B; Botti A; Borca VC; Cattari G; Civardi F; Esposti CD; Franco P; Girelli G; Maggio A; Muraglia A; Palombarini M; Pierelli A; Pignoli E; Vavassori V; Zeverino M; Valdagni R; Fiorino C
Radiother Oncol; 2014 Apr; 111(1):100-5. PubMed ID: 24631144
[TBL] [Abstract][Full Text] [Related]
39. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland.
Desai J; Stock RG; Stone NN; Iannuzzi C; DeWyngaert JK
Radiat Oncol Investig; 1998; 6(3):135-41. PubMed ID: 9652912
[TBL] [Abstract][Full Text] [Related]
40. Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer.
Egawa S; Shimura S; Irie A; Kitano M; Nishiguchi I; Kuwao S; Hayakawa K; Baba S
Jpn J Clin Oncol; 2001 Nov; 31(11):541-7. PubMed ID: 11773262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
